Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

GX China Biotech Innovation ETF (CHB)

GX China Biotech Innovation ETF (CHB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family Global X Mgt
  • Assets Under Management 1,394,400
  • Shares Outstanding, K 210
  • 60-Month Beta 0.29
Trade CHB with:
  • Price/Earnings ttm 26.42
  • Annual Dividend & Yield 0.04 (0.59%)
  • Most Recent Dividend 0.002 on 12/28/23
  • Management Fee 0.65%
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.63 +0.15%
on 02/15/24
7.08 -6.21%
on 01/17/24
-0.65 (-8.92%)
since 01/16/24
3-Month
6.63 +0.15%
on 02/15/24
8.57 -22.52%
on 11/28/23
-1.45 (-17.92%)
since 11/16/23
52-Week
6.63 +0.15%
on 02/15/24
10.07 -34.06%
on 03/01/23
-3.29 (-33.10%)
since 02/16/23

Most Recent Stories

More News
The Zacks Analyst Blog Highlights CHB, PGJ, CXSE, KEJI and MCH

CHB, PGJ, CXSE, KEJI and MCH are part the Zacks top Analyst Blog.

CXSE : 26.43 (+1.03%)
PGJ : 24.68 (+0.69%)
CHB : 6.64 (-0.38%)
KEJI : 10.88 (+0.65%)
MCH : 18.83 (+1.05%)
5 ETFs Riding Higher on a China Stock Rally

After a $3.9 trillion rout, Chinese stocks have staged a strong comeback this year. The MSCI China Index has risen 12.4% in the initial weeks of 2023, marking the best start to a year since 1996.

CXSE : 26.43 (+1.03%)
PGJ : 24.68 (+0.69%)
CHB : 6.64 (-0.38%)
KEJI : 10.88 (+0.65%)
MCH : 18.83 (+1.05%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Fund Summary

The Global X China Biotech Innovation ETF seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive China Biotech Innovation Index.

See More

Top 10 Holdings

Name % Holdings
GX China Biotech Innovation ETF 0.00%
N/A 0.00%

See More

Key Turning Points

3rd Resistance Point 6.74
2nd Resistance Point 6.72
1st Resistance Point 6.68
Last Price 6.64
1st Support Level 6.62
2nd Support Level 6.60
3rd Support Level 6.56

See More

52-Week High 10.07
Fibonacci 61.8% 8.76
Fibonacci 50% 8.35
Fibonacci 38.2% 7.94
Last Price 6.64
52-Week Low 6.63

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar